HighMark Wealth Management »

Edgewise Therapeutics shares owned by HighMark Wealth Management

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by HighMark Wealth Management from 13F filings

Historical chart of HighMark Wealth Management investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by HighMark Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by HighMark Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $863k 53k 16.22
2025-06-30 $683k 52k 13.11
2025-03-31 $3.6k 165 22.00
2024-12-31 $4.4k 165 26.70

More positions owned by HighMark Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Us Vlu (IUSV)
Wells Fargo & Company (WFC)
Performant Finl (PHLT)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Anaptysbio Inc Common (ANAB)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Ishares Tr Core S&p Mcp Etf (IJH)
Axogen (AXGN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Neogenomics Com New (NEO)

View all positions for HighMark Wealth Management

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
Baker Bros. Advisors
BlackRock
Paradigm Biocapital Advisors
Novo A/S
Braidwell
Henderson Group
Vanguard Group
Cormorant Asset Management
Siren
Perceptive Advisors
Bellevue Group
Driehaus Capital Management
MPM Oncology Impact Management

View all funds holding Edgewise Therapeutics